New Delhi: Mumbai-based mostly income cycle administration solutions supplier Infinx has acquired US-based prior authorisation processing agency Glidian for an undisclosed quantity.
In a press release, Infinx introduced that each corporations have constructed integrations with a number of nationwide payers. By merging these connections, the mixed entity goals to improve efficiencies and streamline workflows for patrons.
Collectively, Infinx and Glidian now course of a median of 700,000 patient access transactions per 30 days, reinforcing their place as a frontrunner in patient access automation.
Commenting on the acquisition, Jaideep Tandon, CEO, Infinx, mentioned, “Glidian’s experience in prior authorisation know-how, significantly within the laboratory area, enhances Infinx’s suite of patient access solutions. We’re excited to welcome the Glidian workforce to the Infinx household and look ahead to driving continued innovation to deal with challenges in patient access and prior authorisation.”
Ashish Dua, CEO , Glidian, added, “With Infinx’s sources and experience, we are able to additional speed up prior authorization automation and develop our product choices, in the end enhancing the patient access expertise.”
The acquisition strengthens Infinx’s foothold within the laboratory market, the place Glidian has achieved complete market protection. By combining Infinx’s AI-pushed platform with Glidian’s established solutions, prospects can count on a seamless and extra environment friendly prior authorisation course of.
Source link
#Infinx #acquires #USbased #Glidian #strengthen #patient #access #solutions #HealthWorld
